WP
QNRX

Woodline Partners’s Quoin Pharmaceuticals QNRX Stock Holding History

Woodline Partners’s Portfolio QNRX Stock Details QNRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$525K Hold
79,582
– – ﹤0.01% 957
2025
Q4 		$1.15M Buy
+79,582
New +$1.08M ﹤0.01% 832

Other funds holding QNRX

IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
DIG
Dauntless Investment Group Etna, New Hampshire $151M AUM 76.14% 1-Year Est. Return
SC
SummitTX Capital Fort Worth, Texas $3.2B AUM 41.22% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
CC
Centiva Capital New York $13.6B AUM 20% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Woodline Partners's QNRX Position: Q1 2026 in Review

Woodline Partners held its Quoin Pharmaceuticals (QNRX) position steady in Q1 2026 at 79,582 shares worth $525K. The position accounts for ﹤0.01% of the portfolio, ranked #957.

Woodline Partners first reported a position in QNRX in Q4 2025 and has held it in 2 quarters since. The position peaked at $1.15M in Q4 2025. 22 funds tracked by Wall St. Rank hold QNRX as of Q1 2026.

  • Woodline Partners held 79,582 shares of Quoin Pharmaceuticals worth $525K as of Q1 2026.
  • Woodline Partners left its Quoin Pharmaceuticals share count unchanged in Q1 2026.
  • Quoin Pharmaceuticals made up ﹤0.01% of Woodline Partners's portfolio in Q1 2026, its #957 holding.
  • Woodline Partners first reported a position in Quoin Pharmaceuticals in Q4 2025 and has held it in 2 quarters since.
  • Woodline Partners's Quoin Pharmaceuticals position peaked at $1.15M in Q4 2025.
  • 22 funds tracked by Wall St. Rank held Quoin Pharmaceuticals as of Q1 2026.

Based on Woodline Partners's 13F filing for Q1 2026, filed 15 May 2026.